about
Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+.Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia.Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.Acid-base and electrochemical properties of manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: potentiometric, spectrophotometric and spectroelectrochemical study of protolytic and redox equilibria.A simple three-step method for design and affinity testing of new antisense peptides: an example of erythropoietin.Acid-base and electrochemical properties of manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: voltammetric and chronocoulometric study of protolytic and redox equilibria.Thermal stability of the prototypical Mn porphyrin-based superoxide dismutase mimic and potent oxidative-stress redox modulator Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP(5+).Acido-base behavior of hydroxamic acids: experimental and ab initio studies on hydroxyureas.Interaction of α-melanocortin and its pentapeptide antisense LVKAT: effects on hepatoprotection in male CBA miceThermal analysis of N-carbamoyl benzotriazole derivativesHepatoprotective effects of Met-enkephalin on acetaminophen-induced liver lesions in male CBA mice
P50
Q34455737-B86D02CC-BF93-451E-9E52-3AEBCB72D24BQ35428090-6E669A7D-4C04-4AB0-A838-80594C9E1C53Q36256658-57841AFA-8ABE-42BA-8BCA-42B6DBE442D8Q37063743-16D48EFD-283C-4205-BB88-1DC98632D633Q37148919-AA7133BA-E339-4FA1-9EBA-2FE38308CF1FQ37734008-2660E525-FA53-48C8-85C9-B46C73D61762Q38053032-098C9D70-C17C-4B05-A3EC-334A1B76A047Q41812704-A978B941-89AE-413E-85FA-131A4014AF32Q41838502-7D4A3A1A-766E-4791-9302-D7E60BB5345FQ42052201-BBDEF109-AECA-4FC3-ABE9-B3C3844ECA3AQ42767664-64D68E6C-0B56-4862-B9E7-B0E07ABFF95DQ43042063-25D05BE0-A875-49A4-97AE-B59BF7398B87Q46298421-11957EB8-635D-496E-8330-8A77B975DA03Q84846602-B6B37CC6-A99D-460E-8B64-C8DBCD2C80A9Q85214268-3D672434-9EBF-4EF2-8DAD-523677CD6F7CQ87529947-2899F61C-41F2-473E-976C-FE50DF28317F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tin Weitner
@ast
Tin Weitner
@en
Tin Weitner
@es
Tin Weitner
@nl
Tin Weitner
@sl
type
label
Tin Weitner
@ast
Tin Weitner
@en
Tin Weitner
@es
Tin Weitner
@nl
Tin Weitner
@sl
prefLabel
Tin Weitner
@ast
Tin Weitner
@en
Tin Weitner
@es
Tin Weitner
@nl
Tin Weitner
@sl
P106
P1153
23006381700
P21
P31
P3835
tin-weitner
P496
0000-0003-4132-2295
P569
2000-01-01T00:00:00Z